These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6181452)

  • 21. Reduction of immediate complications after panretinal photocoagulation.
    Liang JC; Huamonte FU
    Retina; 1984; 4(3):166-70. PubMed ID: 6494634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of proliferative diabetic retinopathy with panretinal cryotherapy.
    Daily MJ; Gieser RG
    Ophthalmic Surg; 1984 Sep; 15(9):741-5. PubMed ID: 6208524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization.
    Tasman W; Magargal LE; Augsburger JJ
    Ophthalmology; 1980 May; 87(5):400-2. PubMed ID: 6157141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Internal ophthalmoplegia after argon laser panretinal photocoagulation.
    Rogell GD
    Arch Ophthalmol; 1979 May; 97(5):904-5. PubMed ID: 571710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    ; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
    JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xenon arc photocoagulation of proliferative diabetic retinopathy. A review of 2688 consecutive eyes in the format of the Diabetic Retinopathy Study.
    Okun E; Johnston GP; Boniuk I; Arribas NP; Escoffery RF; Grand MG
    Ophthalmology; 1984 Dec; 91(12):1458-63. PubMed ID: 6084216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute pressure elevation following panretinal photocoagulation.
    Blondeau P; Pavan PR; Phelps CD
    Arch Ophthalmol; 1981 Jul; 99(7):1239-41. PubMed ID: 7196215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy.
    Aylward GW; Pearson RV; Jagger JD; Hamilton AM
    Br J Ophthalmol; 1989 Mar; 73(3):197-201. PubMed ID: 2468355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the visual field and dark adaptation following panretinal photocoagulation in diabetic retinopathy].
    Prskavec FH; Fulmek R; Klemen C; Stelzer N
    Klin Monbl Augenheilkd; 1986 Nov; 189(5):385-7. PubMed ID: 2433497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe proliferative diabetic retinopathy treated with vitrectomy or panretinal photocoagulation: a monocenter randomized controlled clinical trial.
    Avitabile T; Bonfiglio V; Castiglione F; Castaing M; Contarino F; Mistretta A
    Can J Ophthalmol; 2011 Aug; 46(4):345-51. PubMed ID: 21816255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study.
    Muqit MM; Marcellino GR; Henson DB; Young LB; Patton N; Charles SJ; Turner GS; Stanga PE
    Arch Ophthalmol; 2010 May; 128(5):525-33. PubMed ID: 20457972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation.
    Doft BH; Metz DJ; Kelsey SF
    Ophthalmology; 1992 Nov; 99(11):1728-34; discussion 1734-5. PubMed ID: 1454350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity.
    Hamilton AM; Townsend C; Khoury D; Gould E; Blach RK
    Trans Ophthalmol Soc U K (1962); 1981; 101(1):87-92. PubMed ID: 6192562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single session of Pascal versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparitive study.
    Muraly P; Limbad P; Srinivasan K; Ramasamy K
    Retina; 2011; 31(7):1359-65. PubMed ID: 21423068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative use of diode and argon laser for panretinal photocoagulation in diabetic retinopathy].
    Ulbig MW; Hamilton AM
    Ophthalmologe; 1993 Oct; 90(5):457-62. PubMed ID: 8219631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1.
    Ophthalmology; 1993 Nov; 100(11):1655-64. PubMed ID: 8233391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Photocoagulation dosage in proliferative diabetic retinopathy].
    Gerke E; Meyer-Schwickerath G
    Fortschr Ophthalmol; 1983; 80(4):339-41. PubMed ID: 6195059
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of argon laser photocoagulation on diabetic retinopathy].
    Wei ZY; Hu SX; Tang N; Wu J; Wang J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser.
    Hercules BL; Gayed II; Lucas SB; Jeacock J
    Br J Ophthalmol; 1977 Sep; 61(9):555-63. PubMed ID: 336079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.